验证数据展示
经过测试的应用
| Positive IF-P detected in | human appendicitis tissue, human tonsillitis tissue |
Planning an IHC experiment? We recommend our IHCeasy human IgM Ready-To-Use IHC Kit. human IgM primary antibody included.
For other applications, we recommend the unconjugated version of this antibody, 66484-1-Ig
推荐稀释比
| Application | Dilution |
|---|---|
| Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
发表文章中的应用
| WB | See 1 publications below |
| IF | See 1 publications below |
产品信息
CL488-66484 targets human IgM in WB, IF-P applications and shows reactivity with human samples.
| Tested Applications | IF-P Application Description |
| Cited Applications | WB, IF |
| Tested Reactivity | human |
| Cited Reactivity | human |
| Immunogen | human IgM fusion protein Ag1459 种属同源性预测 |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Full Name | immunoglobulin heavy constant mu |
| Synonyms | IgM, IGHM, VH, MU, 2D10B10 |
| Calculated Molecular Weight | 69 kDa |
| Observed Molecular Weight | 75 kDa |
| GenBank Accession Number | BC009851 |
| Gene Symbol | IGHM |
| Gene ID (NCBI) | 3507 |
| RRID | AB_2883344 |
| Conjugate | CoraLite® Plus 488 Fluorescent Dye |
| Excitation/Emission Maxima Wavelengths | 493 nm / 522 nm |
| Form | Liquid |
| Purification Method | Protein G purification |
| Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
| Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
实验方案
| Product Specific Protocols | |
|---|---|
| IF protocol for CL Plus 488 human IgM antibody CL488-66484 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
发表文章
| Species | Application | Title |
|---|---|---|
Oncol Lett Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells. | ||
Rapid Commun Mass Spectrom iTRAQ-based quantitative proteomic analysis of immune thrombocytopenia patients before and after Qishunbaolier treatment. |
